United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
568.43
+2.56 (0.45%)
May 22, 2026, 4:00 PM EDT - Market closed
United Therapeutics Employees
United Therapeutics had 1,400 employees as of December 31, 2025. The number of employees increased by 95 or 7.28% compared to the previous year.
Employees
1,400
Change (1Y)
95
Growth (1Y)
7.28%
Revenue / Employee
$2,264,143
Profits / Employee
$919,571
Market Cap
24.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,400 | 95 | 7.28% |
| Dec 31, 2024 | 1,305 | 137 | 11.73% |
| Dec 31, 2023 | 1,168 | 183 | 18.58% |
| Dec 31, 2022 | 985 | 20 | 2.07% |
| Dec 31, 2021 | 965 | 15 | 1.58% |
| Dec 31, 2020 | 950 | 30 | 3.26% |
| Dec 31, 2019 | 920 | 60 | 6.98% |
| Dec 31, 2018 | 860 | 60 | 7.50% |
| Dec 31, 2017 | 800 | 50 | 6.67% |
| Dec 31, 2016 | 750 | 0 | - |
| Dec 31, 2015 | 750 | 10 | 1.35% |
| Dec 31, 2014 | 740 | 34 | 4.82% |
| Dec 31, 2013 | 706 | 83 | 13.32% |
| Dec 31, 2012 | 623 | 80 | 14.73% |
| Dec 31, 2011 | 543 | 23 | 4.42% |
| Dec 31, 2010 | 520 | 110 | 26.83% |
| Dec 31, 2009 | 410 | 50 | 13.89% |
| Dec 31, 2008 | 360 | 40 | 12.50% |
| Dec 31, 2007 | 320 | 35 | 12.28% |
| Dec 31, 2006 | 285 | 75 | 35.71% |
| Dec 31, 2005 | 210 | 40 | 23.53% |
| Dec 31, 2004 | 170 | 10 | 6.25% |
| Dec 31, 2003 | 160 | 10 | 6.67% |
| Dec 31, 2002 | 150 | 22 | 17.19% |
| Dec 31, 2001 | 128 | 18 | 16.36% |
| Dec 31, 2000 | 110 | 47 | 74.60% |
| Dec 31, 1999 | 63 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Alkermes | 2,050 |
UTHR News
- 6 days ago - United Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 days ago - United Therapeutics says TETON-1 study published in NEJM - TheFly
- 6 days ago - United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026 - Business Wire
- 8 days ago - United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 - Business Wire
- 9 days ago - United Therapeutics cleared by FDA to proceed with UHeart clinical trial - TheFly
- 9 days ago - United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial - Business Wire
- 12 days ago - United Therapeutics, Varda Space Industries team on use of microgravity - TheFly
- 13 days ago - United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference - Business Wire